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Abstract Current diagnostic practices have shortened the
interval between colorectal cancer (CRC) diagnosis and
genetic analysis for Lynch syndrome by MSI-testing. We
studied the relation of time between MSI-testing since
CRC diagnosis (MSI–CRC interval) and psychological
distress. We performed a cross-sectional study in 89
patients who had previously been treated for CRC. Data
were collected during MSI-testing after genetic counseling.
Psychological distress was measured with the IES, the
SCL-90 and the POMS; social issues with the ISS, ISB and
the ODHCF. The median time of MSI–CRC interval was
24 months (range 0–332), with 23% of the patients diag-
nosed less than 12 months and 42% more than 36 months
prior to MSI-testing. In 34% of the patients cancer speciﬁc
distress was high (IES scores[26). Mean psychopathology
(SCL-90) scores were low, mean mood states (POMS)
scores were moderate. Interval MSI–CRC was not related
to psychological distress. High cancer speciﬁc distress was
reported by 24% of patients diagnosed with CRC less than
12 months ago versus 39 and 35% by those diagnosed
between 12 and 36 months and more than 36 months ago
respectively. Distress was positively related to female
gender (P = 0.04), religiousness (P = 0.01), low social
support (P = 0.02) and difﬁculties with family communi-
cation (P\0.001). Shortened time interval between CRC
diagnosis and MSI-testing is not associated with higher
psychological distress. Females, religious persons, those
having low social support and those reporting difﬁculties
communicating hereditary colorectal cancer with relatives
are at higher risk for psychological distress.
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Introduction
In The Netherlands more than 11,000 people are diagnosed
with colorectal cancer each year [1]. This means that
around 1 in 20 Dutch people will develop colorectal cancer
in their lifetime. The majority of colorectal cancer patients
have sporadic disease and only a minority of colorectal
cancers has a genetic cause. One well-described colorectal
cancer genetic syndrome is Lynch syndrome which is
estimated to account for 3–5% of all colorectal cancer
[2, 3]. Lynch syndrome is an autosomal dominant inherited
disorder characterized by an increased risk to develop
colorectal cancer (60–90% lifetime risk) and an increased
risk of extra-colonic tumors, especially endometrial cancer
(25–70% lifetime risk); the age at diagnosis for colorectal
cancer is most often between 41 and 54 years, for endo-
metrial cancer between 45 and 50 years [2, 3]. Lynch
syndrome mutation carriers are advised to have regular
colorectal screening, starting at the age of 25, with a
maximum interval of 24 months between each examination
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DOI 10.1007/s10689-010-9387-9[4]. Regular surveillance reduces morbidity and mortality
by 65% over 15 years in previously unaffected relatives
and also reduces the risk of a second colorectal cancer in
patients [5]. Lynch syndrome is caused by mutations in one
of the mismatch repair (MMR) genes and is characterized
by tumors that show microsatellite instability (MSI), which
is found in more than 90 percent of tumors from patients
with Lynch syndrome [2]. In current practice, MSI analysis
is used as a pre screening tool selecting families for further
analysis of MMR gene defects [6].
Undoubtedly cancer diagnosis is a traumatic life event
[7]. Genetic counseling and testing for hereditary cancer
can also be a strong stressor [8]. It may cause uncertainty
about future cancer which may lead to an increased level of
cancer speciﬁc distress, activating intrusion or avoidance or
both [9]. After genetic counseling, greater awareness of the
increased risk of second cancer and of the genetic contri-
bution to an increased risk of cancer for their children may
lead to an increased level of cancer speciﬁc distress [8].
Additionally a positive genetic test result may reactivate or
aggravate distress related to cancer diagnosis and treatment
[10].
Studies, which address the psychological impact of
genetic counseling and testing for hereditary colorectal
cancer in healthy individuals or given time after cancer
diagnosis, generally indicate that genetic information does
not result in adverse psychological outcomes in the long
term [11–14]. However, due to a change in various pro-
tocols, the time between colorectal cancer diagnosis and
genetic counseling and testing for Lynch syndrome is
decreasing. This is partly due to MSI testing by patholo-
gists, for instance in tissue of patients diagnosed before age
50 or from patients with a second CRC before age 70 [15].
A striking psychological difference with former practice is
that these patients are confronted with a possibly hereditary
predisposition for Lynch syndrome coincident with treat-
ment for CRC. Little is known about the psychosocial
impact of genetic testing in patients with a recent diagnosis
of colorectal cancer.
The aim of the current study is to investigate whether
high levels of overall psychological distress are present
during MSI-testing and whether these levels are correlated
with time since colorectal cancer diagnosis. For that
purpose we use both the Impact of Event Scale (IES), the
Symptom Checklist-90 and the Proﬁle Of Mood States
(POMS); the IES because more recently diagnosed
patients might be more vulnerable to reactivation or
aggravation of cancer speciﬁc distress and the SCL-90 and
the POMS to measure general psychological distress
during the past week. Concerns of heredity mediated
distress and cancer speciﬁc distress may affect both the
overall level of distress. However, this cannot be distin-
guished in our sample.
Materials and methods
Study design and procedure
A cross-sectional study was performed to determine psy-
chological distress in patients previously treated for colo-
rectal cancer just after initiation of MSI testing. All patients
visited the Department of Clinical Genetics of the Radboud
University Medical Centre Nijmegen in the Netherlands.
Before MSI-testing was started, comprehensive genetic
counseling took place to ensure that the patient understands
the implications of the MSI-test. MSI-testing was per-
formed after informed consent of the patient. Inclusion
criteria of the study were (1) patients with colorectal cancer
(2) fulﬁlling one of the Bethesda criteria for MSI-testing
[4] and (3) having a CRC to be tested for MSI. Patients
were excluded in case of (1) previous MSI-testing or (2)
current treatment for psychiatric disorders. In every patient
medical history for psychiatric disorders and former and
current psychiatric treatment is taken. From Augustus 2007
to September 2009, 191 eligible patients were approached
by their genetic counselor (n = 14) to participate the study.
Of these potential eligible patients16 patients considered
participating too stressful, three patients were in a terminal
phase and two patients had already received the MSI-test
result. Four patients were in current psychiatric treatment
and therefore excluded from study participation. Of 77
from the remaining 81 patients personal reasons for non-
participation were retrieved being ‘‘not interested’’ (64%),
‘‘too busy’’ (25%) and ‘‘just forgotten’’ (11%). Finally,
written informed consent was obtained from 89 partici-
pants in accordance to the rules of the Committee on
Research Involving Human Subjects, Region Arnhem-
Nijmegen in the Netherlands. Psychological and social data
were collected by validated questionnaires immediately
after initiation of MSI-testing, still before MSI-test dis-
closure. Information regarding family cancer history was
retrieved from medical records.
Measures
Demographic and colorectal cancer information
Data were obtained on age, gender, marital and parental
status, education, religion, cancer status and on having a
ﬁrst degree relative with cancer.
Psychological distress
Cancer speciﬁc distress
The Impact of Event Scale (IES) [16, 17] was geared
towards colorectal cancer as distressing event (scoring
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1230,1,3,5). A total score of 9–25 reﬂects moderate adaptation
difﬁculties, a score above 26 indicates serious adaptation
difﬁculties [18]. The IES is widely used as a measure of
cancer speciﬁc distress within the context of genetic
counselling and testing for hereditary cancer [19, 20].
Psychopathology
The Symptom Checklist-90 (SCL-90) is a 90-item indica-
tor for psychopathology. A SCL-90 score above 160 is
indicative for serious psychological complaints, a score
above 200 is indicative for a psychiatric disorder [21].
Mood states
The Proﬁle of Mood States-Brief (POMS-SF) [22] mea-
sures depression (range 0–32), anger (range 0–28), fatigue
(range 0–24), tension (range 0–24) and vigour (range
0–20).
Social support
The Inventory for Social Support (ISS) [23] comprises 3
scales: potential emotional trust (range 5–20), actual trust
(range 3–12) and visits (range 2–8).
Family communication
Family communication was assessed with an adaptation of
the Openness to Discuss Hereditary Cancer in the Family
Scale (ODHCF) [24, 25]. Openness was assessed with the
item ‘‘I discuss hereditary colorectal cancer with my part-
ner, children, parents, brothers, sisters, uncles and aunts,
nephews and nieces, respectively, i.e. never (1), rarely (2),
sometimes (3) and often (4)’’. Family communication dif-
ﬁculties and in need of help were assessed similarly (range
7–24).
Statistical analysis
The SPSS 16.0 statistical package was used to analyze the
data. Correlations between cancer speciﬁc distress (IES),
psychopathology (SCL-90) and mood states (POMS) were
assessed by the Spearman’ Rank Correlation. Time
between colorectal cancer (CRC) diagnosis and the initia-
tion of MSI-testing was deﬁned as ‘‘Interval MSI–CRC’’
and measured in months. Interval MSI–CRC was divided
in 3 categories: shortly after CRC diagnosis (\12 months
after diagnosis), recuperating from cancer treatment
(12–36 months after diagnosis) and diagnosed with cancer
longer ago ([36 months after diagnosis). Interrelations
between the interval CRC-MSI, various other personal
variables (i.e. gender, marital and parental status, religion,
cancer and cancer treatment related, having a ﬁrst degree
relative with cancer, social support, family communica-
tion) and cancer speciﬁc distress were analyzed. The IES
was dichotomized, where 26 was used as cut-off value
for clinically high levels of psychological distress [16].
Multivariate logistic regression analysis was performed for
all variables that were analyzed in univariate analysis and
were statistically signiﬁcant correlated with the IES[26,
with stepwise removal of non-signiﬁcant variables. Odds
ratios (OR’s) were calculated to describe associations
between personal characteristics and the IES[26 and
presented with their 95% conﬁdence intervals (95% CI).
P-values \0.05 were considered statistically signiﬁcant
(two-tailed).
Results
Study sample
From August 2007 till September 2009, 193 patients with a
history of colorectal cancer were approached by their
genetic counselor after genetic counseling and initiation of
MSI analysis. Eighty-nine patients were included (response
rate 46%). No signiﬁcant differences were found regarding
sociodemographic and colorectal cancer related character-
istics between participants and non-participants.
Sociodemographic and colorectal cancer related
characteristics
Most participants were female (64%), married or cohabit-
ing (83%), had children (88%) and considered themselves
religious (72%). The median age at CRC diagnosis was
49 years with the youngest patient diagnosed at age
24 years. The median age at initiating MSI-testing was
55 years (range 32–85 years). The median time of the
CRC-MSI interval was 24 months (range 0–332 months).
So the range in time since cancer diagnosis was large, with
23% of the patients diagnosed less than 12 months and
42% of the patients diagnosed with cancer more than
36 months ago. Colorectal cancer related characteristics of
the study sample are provided in Table 1.
Social characteristics
Social support and family communication characteristics
are provided in Table 2. Mean social support scores were
comparable to those of a norm group in the Dutch popu-
lation [23]. The mean family communication openness
score was moderate; mean family communication difﬁ-
culties and in need of help scores were low. Of the males,
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12322% reported difﬁculties regarding family communication
about hereditary colorectal cancer versus 55% of the
females. Regarding the item ‘‘in need of help’’, 25% of the
males versus 46% of the females felt the need for help in
discussing hereditary cancer with the family.
Levels of psychological distress
The mean level of psychological distress (IES) was 16.90
(SD 21.7). More than one-third of the study sample
reported clinically elevated levels of distress (IES[26), of
whom 39% females and 25% males. Signiﬁcantly more
patients who considered themselves religious reported an
IES level above 26 compared to non-religious patients
(41% vs. 16%, P = 0.04). Patients who reported difﬁcul-
ties regarding family communication were more likely to
report an IES level above 26 (47%) than patients with good
family communication (24%) (P = 0.02). Of the patients
diagnosed with colorectal cancer less than 12 months ago
fewer reported high psychological distress (24%), than
patients diagnosed between 12–36 months ago (39%) and
those diagnosed more than 3 years ago (35%).
Relations with the total level of psychological
distress (IES-total)
In Table 3 Spearman rank correlations between patient’s
personal sociodemographic/psychosocial characteristics
and the total level of psychological distress are shown. The
total level of psychological distress was signiﬁcantly cor-
related with gender (P = 0.04), being religious (P = 0.01),
social support visits (P = 0.02), family communication
difﬁculties (P\0.001) and family communication in need
of help (P = 0.009). No relation was found of time
between CRC diagnosis and MSI-testing with levels of
psychological distress.
Relations with high levels of psychological
distress (IES[26)
Being religious and family communication difﬁculties
were signiﬁcantly correlated with high levels of psycho-
logical distress, OR 0.28 (95% CI 0.09–0.91; P = 0.03)
and OR 0.34 (95% CI 0.14–0.85; P = 0.02), respectively.
Multivariate logistic regression analysis showed that the
presence of high psychological distress was independently
related to family communication difﬁculties, OR 0.37
(95% CI 0.14–0.95; P = 0.04).
Psychopathology and mood states
Psychopathology and mood states scores of the study
sample are shown in Table 2. The mean psychopathology
scores of our participants were low [21], while three
patients reported high levels of psychopathology (mean
229, range 209–255). Mean POMS subscales scores were
Table 1 Colorectal cancer (CRC) related characteristics of the study
sample
Patients with a history
of CRC (n = 89)
n %
Lynch syndrome alert
CRC\50 years 52 58
29 Lynch syndrome related
tumor
a\70 years
37 42
First degree relative with cancer 65 73
Cancer treatment
Surgery without adjuvant therapy 36 40
Surgery with chemotherapy (CT) 44 49
Surgery with radiotherapy (RT) 21 24
Surgery with both CT and RT 12 13
Time between CRC and MSI-analysis
\12 months 21 23
12–36 months 31 35
[36 months 37 42
a Endometrial cancer and carcinomas of stomach, small bowl, biliary
tract, brains, sebaceous gland, upper urinary tract and ovaries
Table 2 Psychological and social characteristics of the study sample
Patients with a history of CRC (n = 89)
Mean SD
Mood states
a
Depression 2.6 4.8
Anger 2.7 4.5
Fatigue 5.4 5.7
Tension 3.2 4.4
Vigor 10.7 4.7
Psychopathology
b 122.8 30.6
Social anxiety
c 111.4 15.3
Social support
d
Potential trust 17.1 3.3
Actual trust 7.2 1.9
Visits 6.2 1.2
Family communication
e
Openness 14.4 4.1
Difﬁculties 8.3 4.9
In need of help 7.0 5.0
a POMS brief
b SCL-90
c ISS
d ISS
e ODHCF
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123higher compared to patients with gynaecological cancer of
whom the majority experienced stage I disease [26] but
lower than patients with cancer awaiting bone marrow
transplantation [27]. No statistically signiﬁcant correlations
were found between ‘‘Interval MSI–CRC’’ and the SCL-90
or between ‘‘Interval MSI–CRC’’ and the ‘‘POMS sub-
scales’’. The SCL-90 and the POMS correlated signiﬁ-
cantly with the IES and to avoid duplication of results we
decided not to report all retrieved data.
Discussion
The ﬁndings suggest that the level of psychological dis-
tress is not related to time between colorectal cancer
diagnosis and MSI testing. In fact, patients diagnosed with
colorectal cancer less than 1 year ago reported less psy-
chological distress than patients diagnosed with cancer
longer ago. Contemplation and consideration of the cancer
is more likely to occur once active treatment for cancer in
the hospital is over. Experiencing intrusive thoughts may
be a signal that people are working through the implica-
tions of the cancer [28]. In line with this, a previous study
showed that 15% of patients with breast cancer became
distressed not until after end of treatment, in the reentry
phase [29].
Our study results indicate that in general genetic testing
during the treatment phase of CRC may not be harmful for
patients with CRC. However, approximately one-third of
the patients reported clinically high levels of psychological
distress. The prevalence rate of high cancer distress is
higher than the 3–24% reported in the literature [8, 13, 19,
30–32]. This might be explained by selection bias whereby
individuals who chose to participate in the study were more
distressed compared to those who did not.
We analysed which patients were at highest risk for
distress and found three risk factors: gender, religion and
reduced social support including impaired family commu-
nication. In our study female patients reported higher levels
of psychological distress than male patients. This ﬁts with
many other studies in which gender is found to be related to
psychological distress upon genetic testing [33] and with a
review which demonstrated that female patients with
colorectal cancer are most vulnerable for hereditary cancer
genetic testing related distress [34]. Unexpectedly, reli-
gious patients were found to report the highest levels of
psychological distress. Previous studies showed that
patients use spiritual and religious resources to understand
and cope with morbidity and mortality [35] and that this
helps people cope with genetic uncertainty [36]. We note
that there are positive and negative patterns of religious
coping [35] and in this study we did not measure distinct
religious coping patterns. It might be that in our study
sample negative religious coping patterns dominated. In a
study with participants tested for BRCA1 mutations no
signiﬁcant associations between religiosity and psycho-
logical distress were observed [37]. We conclude to this
point that religious coping in the context of genetic testing
is an area in which more studies are needed. Finally, low
social support and difﬁculties with family communication
were related to higher levels of psychological distress. This
is consistent with a study among colorectal cancer survi-
vors undergoing genetic testing for Lynch syndrome in
which higher levels of cancer related distress was related to
less social support [38]. Genetic testing and hereditary
cancer are family matters. Family system characteristics
may inﬂuence the way the individual and the family as a
whole copes with hereditary cancer [39]. Our data showed
Table 3 Correlations with the level of colorectal cancer speciﬁc
distress (IES-total)
Patient’s characteristics Colorectal cancerdistress
Rs
a
Sociodemographic
Gender 0.218*
Married or cohabiting -0.029
Having children 0.014
Being religious 0.272**
Colorectal cancer related
Age at diagnosis -0.081
Cancer treatment -0.007
First degree relative with cancer -0.110
Genetic risk assessment
Months between CRC and MSI -0.005
Interval CRC-MSI in 3 time categories
b -0.029
Psychological characteristics
Depression 0.447**
Anger 0.348**
Fatique 0.287**
Tension 0.462**
Vigor -0.279**
Psychopathology 0.532**
Social anxiety -0.080
Social support
Potential trust -0.178
Actual trust 0.119
Visits -0.243*
Family communication
Openness -0.081
Difﬁculties 0.397**
In need of help 0.275**
* P\0.05; ** P\0.01
a Rs, Spearman Rank correlation
b \12 months, 12–36 months and[36 months since CRC diagnosis
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123that difﬁculties and being in need of help regarding family
communication about hereditary cancer were related to
psychological distress. Participants more frequently repor-
ted cancer related distress when they perceived family
communication about hereditary cancer as inhibited [40].
The quality of communication is of paramount importance
where open family communication may be an important
buffer against hereditary cancer distress [40]. Patients who
report difﬁculties regarding communicating hereditary
cancer with the family seems vulnerable to high levels of
psychological distress. Questioning family communication
can identify these patients. Former experiences with cancer
may also play an role in genetic testing responses [41].
Experiences with cancer in the family may result in an
increased psychological vulnerability during genetic testing
for hereditary cancer [25]. However, we found no relation
between either cancer treatment or having a ﬁrst degree
relative with cancer and the level of psychological distress.
The latter ﬁnding is in contrast with a study which showed
that having a ﬁrst degree relative with colorectal disease
predicted a higher level of distress about colorectal cancer
[42]. Previous studies found being unmarried [43] and
having children [33] as predictors of psychological distress
related to genetic testing for hereditary cancer. In our study
sample however, no correlations were found between mar-
ital or parental status and the level of psychological dis-
tress.To our knowledge, this is the ﬁrst study that measures
psychological distress in relation to time between colorectal
cancer diagnosis and genetic testing for hereditary cancer.
Moreover, this is the ﬁrst study measuring psychological
distress at the time of testing for being at high risk for Lynch
syndrome by MSI-analysis. A point of attention is that
response rate was low and our study sample may reﬂect
selection-bias. Although demographic and cancer related
characteristics of the participants and the non-participants
did not differ signiﬁcantly, psychological characteristics of
the non-responders were not obtained. Other limitations of
the study is the relatively small sample size and the cross-
sectional design. To determine the causal effect of MSI-
testing on levels of psychological distress a prospective
randomized study design is preferred.
Our results suggest that high levels of psychological
distress are not related to the duration of the time period
between MSI-testing since CRC diagnosis. We carefully
conclude that patients who are either female, religious,
having low social support or those reporting difﬁculties in
communicating hereditary colorectal cancer with relatives
are at higher risk for psychological distress.
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